The PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel enables labs to conserve resources through the simultaneous detection and differentiation of SARS-CoV-2, influenza A, influenza B, and RSV with differential diagnosis options.
- Resource conservation by allowing simultaneous detection of SARS-CoV-2, influenza A, influenza B, and RSV
- Assay coupled with modular, scalable extraction and liquid handling options suitable to process a broad range of samples every day (a few 100 to over 100,000)
- Each kit contains 96 or 384 tests. The shelf life of all reagents is 12 months when stored properly.
The PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel is manufactured and approved for use by the Therapeutic Goods Administration (TGA) .
Buy PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel for Your WorkPlace
If your company or organisation is interested in rapid testing solutions, contact us today for help procuring the PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel or other rapid tests authorised by the Therapeutic Goods Administration (TGA) .
If you’re interested in rapid testing solutions, contact us today for a quote. You can also place an order for the PKamp™ Respiratory SARS-CoV-2 RT-PCR Panel or other rapid tests approved by the TGA.
Our team at Rapid Tests Australia can also assist with implementing a rapid testing program to protect your workplace from the risks of COVID-19.
